IDRI and Chembio Collaborate for a Low-Cost Test for Visceral Leishmaniasis
Chembio Diagnostic Systems and the Infectious Disease Research Institute (IDRI) announce an agreement for Chembio to use its dual path platform technology to develop and manufacture a device for the diagnosis of visceral leishmaniasis.
Read More